Getnet Yimer
Africa Center(US)International Trachoma Initiative(ET)Addis Ababa University(ET)University of Pennsylvania(US)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Drug-Induced Hepatotoxicity and Protection, HIV/AIDS drug development and treatment, Pneumonia and Respiratory Infections, Pneumocystis jirovecii pneumonia detection and treatment
Most-Cited Works
- → Containment of COVID-19 in Ethiopia and implications for tuberculosis care and research(2020)130 cited
- → Importance of Ethnicity, CYP2B6 and ABCB1 Genotype for Efavirenz Pharmacokinetics and Treatment Outcomes: A Parallel-Group Prospective Cohort Study in Two Sub-Saharan Africa Populations(2013)124 cited
- → Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients(2011)122 cited
- → High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study(2011)121 cited
- → Keratin‐18 and micro RNA ‐122 complement alanine aminotransferase as novel safety biomarkers for drug‐induced liver injury in two human cohorts(2013)117 cited
- → Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial